Ten Years of Parkinson’s Research in Luxembourg Highlighted by Interactive Forum and Future Focus on Precision Medicine

Ten Years of Parkinson’s Research in Luxembourg Highlighted by Interactive Forum and Future Focus on Precision Medicine

(IN BRIEF) Luxembourg’s Parkinson’s community celebrated ten years of collaborative progress in research and patient care through a dedicated event that brought together participants, families, clinicians, and scientists. Organized in a World Café format, the gathering encouraged open discussions on research, clinical practices, and prevention strategies, fostering meaningful engagement between experts and participants. Key speakers highlighted the importance of collaboration in advancing treatment outcomes, while the closing panel explored future priorities such as digital innovation and sustained patient involvement in research. Over the past decade, Luxembourg has built a strong ecosystem connecting all stakeholders, positioning the country to further contribute to breakthroughs in Parkinson’s research, including the development of precision medicine and disease-modifying therapies.

(PRESS RELEASE) LUXEMBOURG, 5-May-2026 — /EuropaWire/ — Luxembourg’s Parkinson’s community recently gathered to mark ten years of progress in research and care, bringing together more than 150 research participants, their families, clinicians, and scientists for a dedicated event at the Parc Hotel Alvisse in Dommeldange. The occasion highlighted a decade of collaboration and achievements in advancing understanding and treatment of Parkinson’s disease across the country.

The event opened with remarks from Rejko Krüger, coordinator of the National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD), alongside Stéphanie Obertin, Minister of Digitalisation and Minister of Research and Higher Education. Both speakers underscored the value of strong cooperation between researchers and healthcare professionals in improving outcomes for individuals living with Parkinson’s disease.

Following the opening session, the programme transitioned into a “World Café” format, where participants engaged in a series of interactive round-table discussions. Specialists in clinical care, research, and prevention shared insights into their respective fields while encouraging open dialogue with attendees. This structure enabled meaningful exchanges, allowing participants to contribute their perspectives and experiences directly.

The event concluded with a final panel discussion focused on future directions, including the role of digital technologies in research and care, as well as the importance of sustained and personalised involvement in research studies. Both individuals living with Parkinson’s disease and healthy volunteers were highlighted as essential contributors to ongoing scientific progress.

Reflecting on the past decade, Prof. Dr. Rejko Krüger noted that Luxembourg has developed a robust and collaborative network connecting patients, clinicians, and researchers. He emphasized that these partnerships will remain crucial in enabling access to innovative, disease-modifying therapies through clinical trials, particularly in the context of precision medicine and preventive approaches.

The closing panel brought together a range of experts and stakeholders, including Thomas Dominique, Government Commissioner for Hospitals; Dr. Joëlle Fritz, Coordinator of the Neurological Disease Pillar at the Luxembourg Research Clinic; Dr. Patricia Conde, researcher in Digital Medicine at the University of Luxembourg; Sylvia Herbrink, Care Coordinator at ParkinsonNet Luxembourg; Lex Kloos, research participant and patient ambassador; and Dr. Alexandre Bisdorff, neurologist and member of the ParkinsonNet steering committee.

By strengthening digital innovation and encouraging continued participation in research initiatives, Luxembourg aims to further enhance its role in advancing knowledge of Parkinson’s disease and improving care outcomes for future generations.

Scientific Contact
Rejko Krüger
National Centre for Excellence in Research on Parkinson’s Disease (NCER-PD) Coordinator
Contact

SOURCE: Luxembourg Institute of Health